Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells.
Nebbioso A, Clarke N, Voltz E, Germain E, Ambrosino C, Bontempo P, Alvarez R, Schiavone EM, Ferrara F, Bresciani F, Weisz A, de Lera AR, Gronemeyer H, Altucci L.
Nebbioso A, et al. Among authors: weisz a.
Nat Med. 2005 Jan;11(1):77-84. doi: 10.1038/nm1161. Epub 2004 Dec 26.
Nat Med. 2005.
PMID: 15619633
Free article.